- Report
- April 2025
Global
From €4475EUR$4,900USD£3,827GBP
- Report
- April 2025
- 183 Pages
Global
From €5343EUR$5,850USD£4,569GBP
- Report
- April 2025
- 200 Pages
Global
From €4101EUR$4,490USD£3,507GBP
- Report
- July 2024
- 100 Pages
Global
From €3425EUR$3,750USD£2,929GBP
- Report
- July 2024
- 150 Pages
Global
From €3425EUR$3,750USD£2,929GBP
- Report
- October 2024
- 194 Pages
Global
From €3238EUR$3,545USD£2,769GBP
€3598EUR$3,939USD£3,076GBP
- Report
- October 2024
- 192 Pages
Global
From €3238EUR$3,545USD£2,769GBP
€3598EUR$3,939USD£3,076GBP
- Report
- November 2024
- 120 Pages
Global
From €5434EUR$5,950USD£4,647GBP
- Report
- August 2024
- 100 Pages
Global
From €5434EUR$5,950USD£4,647GBP
- Report
- April 2025
- 141 Pages
Global
From €2739EUR$2,999USD£2,342GBP
- Report
- July 2024
- 143 Pages
Global
From €2739EUR$2,999USD£2,342GBP
- Report
- March 2025
- 96 Pages
Global
From €5434EUR$5,950USD£4,647GBP
- Report
- July 2024
- 142 Pages
Global
From €2739EUR$2,999USD£2,342GBP
- Report
- April 2025
- 163 Pages
Global
From €5343EUR$5,850USD£4,569GBP
- Report
- April 2025
- 298 Pages
Global
From €5343EUR$5,850USD£4,569GBP
- Report
- April 2025
- 193 Pages
Global
From €5343EUR$5,850USD£4,569GBP
- Report
- February 2025
- 200 Pages
Global
From €4101EUR$4,490USD£3,507GBP
- Report
- February 2025
- 200 Pages
Global
From €4101EUR$4,490USD£3,507GBP
- Report
- April 2025
- 250 Pages
Global
From €4101EUR$4,490USD£3,507GBP
- Report
- April 2025
- 250 Pages
Global
From €4101EUR$4,490USD£3,507GBP

Sacral nerve stimulation (SNS) is a type of neuromodulation therapy used to treat a variety of neurological conditions. It involves the implantation of a small device that sends electrical signals to the sacral nerve, which is located near the tailbone. The device is used to reduce symptoms such as urinary and fecal incontinence, chronic pelvic pain, and overactive bladder. It is also used to treat certain types of constipation.
SNS is a minimally invasive procedure that is typically performed in an outpatient setting. It is considered a safe and effective treatment option for many patients. The device is programmed to deliver electrical signals to the sacral nerve, which can help reduce symptoms and improve quality of life.
The SNS market is a growing segment of the neurology devices industry. It is expected to continue to grow as more patients seek out this treatment option. Companies in the SNS market include Medtronic, Boston Scientific, St. Jude Medical, and Nevro. Show Less Read more